EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience

Delia Gagliardi iD, Eleonora Canzio, Paola Orsini, Pasquale Conti, Vita Sinisi, Cosimo Maggiore, Maria Carla Santarsia, Giuseppina Lagioia, Giovanna Lupis, Isabella Roppa, Gaetano Scianatico, Daniela Mancini und 4 weitere

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Delia Gagliardi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Neonatal Screening, Muscular Atrophy, Spinal, Survival of Motor Neuron 1 Protein. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Mandatory newborn screening (NBS) for spinal muscular atrophy (SMA) was implemented for the first time in Italy at the end of 2021, allowing the identification and treatment of patients at an asymptomatic stage.

Methods

DNA samples extracted from dried blood spot (DBS) from newborns in Apulia region were analysed for SMA screening by using a real‐time PCR‐based assay. Infants harbouring homozygous deletion of SMN1 exon 7 confirmed by diagnostic molecular tests underwent clinical and neurophysiological assessment and received a timely treatment.

Results

Over the first 20 months since regional NBS introduction, four out of 42,492 (0.009%) screened children were found to carry a homozygous deletion in the exon 7 of SMN1 gene, with an annual incidence of 1:10,623. No false negatives were present. Median age at diagnosis was 7 days and median age at treatment was 20.5 days. Three of them had two copies of SMN2 and received gene therapy, while the one with three SMN2 copies was treated with nusinersen. All but one were asymptomatic at birth, showed no clinical signs of disease after a maximum follow‐up of 16 months and reached motor milestones appropriate with their age. The minimum interval between diagnosis and the treatment initiation was 9 days.

Interpretation

The timely administration of disease‐modifying therapies prevented presymptomatic subjects to develop disease symptoms. Mandatory NBS for SMA should be implemented on a national scale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningMuscular Atrophy, SpinalSurvival of Motor Neuron 1 ProteinHumansItalyInfant, NewbornFemaleMaleSurvival of Motor Neuron 2 ProteinOligonucleotidesInfant

Substanzen

Survival of Motor Neuron 1 ProteinSurvival of Motor Neuron 2 ProteinOligonucleotides

Autor:innen und Institutionen

  • Dino Ferrari Center, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Pediatric Neurology Unit, Pediatric Hospital "Giovanni XXIII", Bari, Italy.
  • Medical Genetic Unit, Department of Reproductive Pregnancy Risk, ASL BARI, Bari, Italy.
  • U.O.C. Medicina Fisica e Riabilitazione, A.O.U. Consorziale Policlinico di Bari, Bari, Italy.
  • Neuromuscular and Rare Disease Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Neurology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

ORCID-Profile: Delia Gagliardi, Stefania Corti, Giacomo Pietro Comi

Förderung

  • Ministero della Salute

Zitieren

APA

Gagliardi, D., Canzio, E., Orsini, P., Conti, P., Sinisi, V., Maggiore, C., Santarsia, M. C., Lagioia, G., Lupis, G., Roppa, I., Scianatico, G., Mancini, D., Corti, S., Comi, G. P., Gentile, M., & Gagliardi, D. (2024). Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52018

Vancouver

Gagliardi D, Canzio E, Orsini P, Conti P, Sinisi V, Maggiore C, et al. Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52018

BibTeX
@article{Gagliardi2024,
  author = {Gagliardi, Delia and Canzio, Eleonora and Orsini, Paola and Conti, Pasquale and Sinisi, Vita and Maggiore, Cosimo and Santarsia, Maria Carla and Lagioia, Giuseppina and Lupis, Giovanna and Roppa, Isabella and Scianatico, Gaetano and Mancini, Daniela and Corti, Stefania and Comi, Giacomo Pietro and Gentile, Mattia and Gagliardi, Delio},
  title = {Early spinal muscular atrophy treatment following newborn screening: A 20‐month review of the first Italian regional experience},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52018}
}
Kostenlos starten →